Tianjin Ringpu Bio-Technology Co.,Ltd.

SZSE:300119 株式レポート

時価総額:CN¥8.5b

Tianjin Ringpu Bio-TechnologyLtd 将来の成長

Future 基準チェック /26

Tianjin Ringpu Bio-TechnologyLtd利益と収益がそれぞれ年間18.3%と15.9%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に10.9% 17.9%なると予測されています。

主要情報

18.3%

収益成長率

17.9%

EPS成長率

Pharmaceuticals 収益成長18.8%
収益成長率15.9%
将来の株主資本利益率10.9%
アナリストカバレッジ

Good

最終更新日21 Nov 2024

今後の成長に関する最新情報

Tianjin Ringpu Bio-Technology Co.,Ltd. Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Aug 26
Tianjin Ringpu Bio-Technology Co.,Ltd. Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Recent updates

Solid Earnings May Not Tell The Whole Story For Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119)

Nov 05
Solid Earnings May Not Tell The Whole Story For Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119)

These 4 Measures Indicate That Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119) Is Using Debt Reasonably Well

Oct 30
These 4 Measures Indicate That Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119) Is Using Debt Reasonably Well

The Market Lifts Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) Shares 36% But It Can Do More

Oct 08
The Market Lifts Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) Shares 36% But It Can Do More

Tianjin Ringpu Bio-Technology Co.,Ltd. Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Aug 26
Tianjin Ringpu Bio-Technology Co.,Ltd. Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Improved Earnings Required Before Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) Shares Find Their Feet

Aug 23
Improved Earnings Required Before Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) Shares Find Their Feet

Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119) Seems To Use Debt Quite Sensibly

Jun 26
Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119) Seems To Use Debt Quite Sensibly

Impressive Earnings May Not Tell The Whole Story For Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119)

Apr 05
Impressive Earnings May Not Tell The Whole Story For Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119)

Tianjin Ringpu Bio-Technology Co.,Ltd.'s (SZSE:300119) Subdued P/E Might Signal An Opportunity

Mar 28
Tianjin Ringpu Bio-Technology Co.,Ltd.'s (SZSE:300119) Subdued P/E Might Signal An Opportunity

業績と収益の成長予測

SZSE:300119 - アナリストの将来予測と過去の財務データ ( )CNY Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/20263,4646185356347
12/31/20253,0765421675598
12/31/20242,6144231074568
9/30/20242,409424326537N/A
6/30/20242,354434186437N/A
3/31/20242,339460196438N/A
12/31/20232,249453134378N/A
9/30/20232,195387129386N/A
6/30/20232,170385156462N/A
3/31/20232,136355139473N/A
1/1/20232,08434717389N/A
9/30/20221,985354-1367N/A
6/30/20221,8753490317N/A
3/31/20221,838369-41287N/A
1/1/20222,00741377383N/A
9/30/20212,03843872358N/A
6/30/20212,11745487408N/A
3/31/20212,106441134438N/A
12/31/20202,000398129388N/A
9/30/20201,895302175460N/A
6/30/20201,737255183417N/A
3/31/20201,613224190396N/A
12/31/20191,467194154384N/A
9/30/20191,34615883264N/A
6/30/20191,26013756216N/A
3/31/20191,20312432167N/A
12/31/20181,19011962175N/A
9/30/20181,17910840155N/A
6/30/20181,157117N/A159N/A
3/31/20181,112112N/A113N/A
12/31/20171,047105N/A110N/A
9/30/20171,008136N/A152N/A
6/30/2017993138N/A155N/A
3/31/2017988140N/A185N/A
12/31/2016970133N/A208N/A
9/30/2016943129N/A214N/A
6/30/2016905113N/A221N/A
3/31/2016832108N/A223N/A
12/31/2015793110N/A225N/A
9/30/201569068N/A172N/A
6/30/201563943N/A131N/A
3/31/201562534N/A140N/A
12/31/201458527N/A130N/A
9/30/201466995N/A138N/A
6/30/2014676113N/A136N/A
3/31/2014722140N/A116N/A
12/31/2013755152N/A89N/A

アナリストによる今後の成長予測

収入対貯蓄率: 300119の予測収益成長率 (年間18.3% ) は 貯蓄率 ( 2.8% ) を上回っています。

収益対市場: 300119の収益 ( 18.3% ) CN市場 ( 26.2% ) よりも低い成長が予測されています。

高成長収益: 300119の収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: 300119の収益 ( 15.9% ) CN市場 ( 13.9% ) よりも速いペースで成長すると予測されています。

高い収益成長: 300119の収益 ( 15.9% ) 20%よりも低い成長が予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: 300119の 自己資本利益率 は、3年後には低くなると予測されています ( 10.9 %)。


成長企業の発掘